Holding(s) in Company

RNS Number : 0737P
AstraZeneca PLC
03 June 2015
 

 

For filings with the FCA include the annex


For filings with issuer exclude the annex



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

AstraZeneca plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):


3. Full name of person(s) subject to the
notification obligation:
iii

The Capital Group Companies, Inc.

4. Full name of shareholder(s)
 (if different from 3.):iv

See Schedule A

5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

1 June 2015

6. Date on which issuer notified:

2 June 2015

7. Threshold(s) that is/are crossed or
reached:
vi, vii

Below 3%



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares

(ISIN: GB0009895292)

31,704,772

31,704,772



    30,437,552

 


 

2.4088%

 

ADRs

(ISIN: US0463531089)

7,433,161

7,433,161



       7,435,104

 


 

0.5884%

 


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 





 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

37,872,656

2.9972%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 

See Schedule A


Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:



14. Contact name:


15. Contact telephone number:




 

Note: Annex should only be submitted to the FCA not the issuer

Annex: Notification of major interests in share


A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

The Capital Group Companies, Inc.

Contact address

(registered office for legal entities)

 

333 South Hope Street, 55th Floor

Los Angeles, California 90071

Phone number & email

 

(213) 615-0469 &

GRGroup@capgroup.com

Other useful information

(at least legal representative for legal persons)

 




B: Identity of the notifier, if applicable

Full name

 

Christopher Aquino

Contact address

 

333 South Hope Street, 55th Floor

Los Angeles, California 90071

Phone number & email

 

(213) 615-0469 &

GRGroup@capgroup.com

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

Fax: (213) 615-4056


C: Additional information


For notes on how to complete form TR-1 please see the FCA website.




 

Schedule A

As of 1 June 2015

 

AstraZeneca PLC

 


Number of Shares

Percent of Outstanding




The Capital Group Companies, Inc. ("CG") holdings

37,872,656

2.997%

Holdings by CG Management Companies and Funds:



Capital Guardian Trust Company

5,512,014

0.436%

Capital International Limited

165,100

0.013%

Capital International Sàrl

154,992

0.012%

Capital International, Inc.

72,900

0.006%

Capital Research and Management Company

31,967,650

2.530%

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBGGDLXGGBGUX

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings